---
figid: PMC9343382__41401_2021_838_Fig1_HTML
pmcid: PMC9343382
image_filename: 41401_2021_838_Fig1_HTML.jpg
figure_link: /pmc/articles/PMC9343382/figure/Fig1/
number: Fig. 1
figure_title: ''
caption: NAD+synthesis via salvage pathway using NAM or NR, de novo pathway using
  tryptophan and preiss-handler pathway using NA as the precursors. NAD+, nicotinamide
  adenine dinucleotide, NAM, nicotinamide; NMN, nicotinamide mononucleotide; NR, nicotinamide
  riboside; NRK, NR kinase; NA, nicotinic acid; TDO, tryptophan 2,3-dioxygenase; IDO,
  indoleamine 2,3-dioxygenase; KFase, kynurenine formamidase; K3H, kynurenine‐3‐hydroxylase;
  AMS, 2‐amino‐3‐muconate‐semialdehyde; ACMS, 2‐amino‐3‐carboxy‐muconate‐semialdehyde;
  ACMSD, ACMS decarboxylase; NAMN, nicotinic acid mononucleotide; QPRT, quinolinate
  phosphoribosyltransferase; PRPP, phosphoribosyl pyrophosphate; NAAD, nicotinic acid
  adenine dinucleotide; NAPRT, nicotinic acid phosphoribosyltransferase; NMNAT, nicotinamide
  mononucleotide adenylyltransferase; NADSYN, NAD+ synthetases.
article_title: 'Reduced nicotinamide adenine dinucleotide phosphate in redox balance
  and diseases: a friend or foe?.'
citation: Nirmala Koju, et al. Acta Pharmacol Sin. 2022 Aug;43(8):1889-1904.
year: '2022'

doi: 10.1038/s41401-021-00838-7
journal_title: Acta Pharmacologica Sinica
journal_nlm_ta: Acta Pharmacol Sin
publisher_name: Springer Nature Singapore

keywords:
- aging
- Alzheimer’s disease
- Parkinson’s disease
- diabetes
- obesity
- cancer

---
